| P2093 | author name string | Murad Mutlu | |
| | Erkan Vuralkan | |
| | Istemihan Akin | |
| | Mustafa Sagit | |
| | Ece Miser | |
| | Sevgi Akaydin | |
| | Ibrahim Hikmet Firat | |
| | Sadık Ardic | |
| P2860 | cites work | Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 |
| | Obstructive sleep apnoea syndrome--an oxidative stress disorder | Q35066278 |
| | Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. | Q35569224 |
| | Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability | Q37361893 |
| | Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease | Q40596987 |
| | Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome | Q40625356 |
| | Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. | Q40731011 |
| | Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein | Q42985684 |
| | Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. | Q44064935 |
| | Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome. | Q46121439 |
| | Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome | Q46549747 |
| | Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study | Q47406734 |
| | Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes | Q47671940 |
| | Does night work favor sleep-related accidents in police officers? | Q47716085 |
| | Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome | Q48581295 |
| | Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study | Q48704784 |
| | Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy | Q48716348 |
| | Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. | Q50756925 |
| | Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model | Q73265468 |
| | Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9 | Q73936948 |
| | Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative | Q74019202 |
| | Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms | Q77559142 |
| | Reactions of lipid-derived malondialdehyde with collagen | Q77955164 |
| | Age-related changes in plasma lipid peroxidation and antioxidant system in humans and rats | Q81695659 |
| P433 | issue | 5 | |
| P304 | page(s) | 1329-1334 | |
| P577 | publication date | 2013-11-19 | |
| P1433 | published in | European Archives of Oto-Rhino-Laryngology | Q2624005 |
| P1476 | title | Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS. | |
| P478 | volume | 271 | |